Table 2.
Summary of the miRNAs analyzed.
| Tissue miRNAs | ||
|---|---|---|
| miRNA ID | Reference describing the miRNA | Potential targets of miRNAs |
| let-7g | Fekete et al. (24) | / |
| miR-100-5p | Pedroza-Torres et al. (26) | / |
| miR-106b | Gao et al. (31) | IER3, GAS5 |
| miR-125a | Fan et al. (27) | STAT3, ERBB2 and ERBB3, VEGF-A |
| miR-125a-5p | Pedroza-Torres et al. (26) | STAT3 |
| miR-125b-5p | Pedroza-Torres et al. (26) | BAK1 |
| miR-143 | Chen et al. (35) | BCL2, KRAS, MACC1 |
| miR-150 | Fekete et al. (24) | / |
| miR-155 | Fekete et al. (24) | / |
| miR-18a | Liu et al. (33) | ATM, PARP |
| miR-181a | Chen et al. (28) Ke et al. (29) |
PRKCD, RalA |
| miR-200a-5p | Pedroza-Torres et al. (26) | NRAS, NR4A1, MAPK8, PDGFA, TCF4, DKK2, PSEN1, FZD1, NOTCH2, NOTCH4 |
| miR-31-3p | Pedroza-Torres et al. (26) | |
| miR-34a | Sun et al. (36) | E2F1 |
| miR-342 | Pedroza-Torres et al. (26) Fekete et al. (24) |
/ |
| miR-3676 | Pedroza-Torres et al. (26) | / |
| miR-375 | Song et al. * (34) | UBE3A, SP1, role in EMT |
| miR-378a | Fekete et al. (24) | / |
| miR-378c | Fekete et al. (24) | / |
| miR-378d-2 | Fekete et al. (24) | / |
| miR-411 | Wei et al. + (30) | STK38L, STK17A |
| miR-492 | Liu et al. (25) | ADAMTS1, CD44, TIMP2, MZF-1, CD147, PTEN, SOX7 |
| miR-502 | Fekete et al. (24) | / |
| miR-5586 | Fekete et al. (24) | FOS, GNB1, CREB1, GNAQ, GRIN2A, GRIN2B, FOS, GSK3B, PPARGC1A, FOXO1 |
| miR-605 | Sun et al. (36) | MDM2 |
| miR-7702 | Fekete et al. (24) | / |
| Circulating miRNAs | ||
| miRNA ID | Reference describing the miRNA | Potential targets of miRNAs |
| miR-145 | Wei et al. (32) | HLTF |
| miR-375 | Song et al. * (34) | UBE3A, SP1, role in EMT |
| miR-411 | Wei et al. + (30) | STK38L, STK17A |
EMT, epithelial–mesenchymal transition; + and * indicate the same study in tissue and circulating miRNAs.